デフォルト表紙
市場調査レポート
商品コード
1370899

バイオポリマーベースの創傷被覆材市場- 世界の産業規模、シェア、動向、機会、および予測、2018年~2028年タイプ別、用途別、エンドユーザー別、地域別、競合別に区分

Biopolymer Based Wound Dressing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type, By Application, By End User, By Region, Competition

出版日: | 発行: TechSci Research | ページ情報: 英文 181 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.53円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

バイオポリマーベースの創傷被覆材市場- 世界の産業規模、シェア、動向、機会、および予測、2018年~2028年タイプ別、用途別、エンドユーザー別、地域別、競合別に区分
出版日: 2023年10月03日
発行: TechSci Research
ページ情報: 英文 181 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

バイオポリマーベースの創傷被覆材の世界市場は、2022年に3億4,078万米ドルと評価され、2028年までの予測CAGRは6.41%で、2028年には4億9,137万米ドルに達すると予測され、予測期間中に大幅な成長が見込まれています。

同市場は、医療業界の中でもバイオポリマー(天然由来または合成ポリマー)由来の創傷被覆材の開拓と利用に重点を置く成長分野です。これらの創傷被覆材は、生体適合性、治癒促進機能、環境に優しい性質により、大きな関心を集めています。

高度な創傷ケアソリューションに対する需要の高まりを受けて、同市場では慢性創傷、外科的切開、熱傷、外傷などさまざまなタイプの創傷に対応するよう設計された革新的な製品を提供しています。この成長の背景には、慢性疾患の蔓延、世界人口の高齢化、より効果的な創傷管理の必要性などがあります。バイオポリマーベースの創傷被覆材は、最適な治癒環境の維持、感染リスクの最小化、患者の快適性の向上といった独自の利点を提供します。

この市場には、製品の特性を高めるための研究開発の継続、安全性と有効性を確保するための規制への配慮、市場での存在感を高めるための戦略的提携などがあります。ヘルスケアシステムが効率的な創傷ケアと患者の転帰を重視する中、バイオポリマーベースの創傷被覆材の世界市場は、医療治療パラダイムの進歩と創傷ケアのニーズの進化への対応において重要な役割を果たし続けています。

市場概要
予測期間 2024-2028
市場規模2022年 3億4,078万米ドル
2028年の市場規模 4億9,137万米ドル
CAGR 2023-2028 6.41%
急成長セグメント キトサン
最大市場 北米

市場促進要因

1.慢性創傷の有病率の上昇:

糖尿病性潰瘍や褥瘡などの慢性創傷の有病率の増加は、バイオポリマーベースの創傷被覆材の世界市場の重要な促進要因です。バイオポリマーベースのドレッシング材は、治癒期間の長期化と感染リスクの増大を特徴とするこれらの創傷を効果的に管理し、治癒を促進するためのオーダーメイドのソリューションを提供します。人口の高齢化や慢性疾患の増加などの要因により慢性創傷の有病率が上昇しており、こうした革新的なドレッシング材の需要に寄与しています。

2.環境に優しく生体適合性の高い素材:

環境維持に対する意識の高まりと生体適合素材へのニーズが市場拡大の原動力となっています。再生可能な素材や生物工学的に設計されたポリマーを原料とするバイオポリマーベースのドレッシング材は、生体適合性を高めながら持続可能性の目標に合致しています。

3.手術件数の増加:

術後の創傷を伴う外科手術の増加が、バイオポリマーベースの創傷被覆材の需要を押し上げています。これらのドレッシング材は手術創特有の治癒ニーズに対応し、生体適合性と最適な治癒環境を提供することで創傷閉鎖を早め、合併症を軽減します。

主な市場課題

1.限られた臨床エビデンス:

バイオポリマーをベースとした創傷被覆材の有効性を裏付ける確かな臨床データがないことが、採用の課題となっています。安全性、有効性、価値を確立するには強力な臨床エビデンスが不可欠であり、この課題を克服するには包括的な調査と協力が必要です。

2.高コスト:

バイオポリマーをベースとした創傷被覆材は、その製造工程や独特の材料特性から、従来の被覆材と比較してコストが高くなる可能性があります。このコストの課題は、価格設定、購入しやすさ、償還の決定に影響します。

3.多様な創傷タイプ:

多様な創傷タイプに対応することは、カスタマイズ、標準化、使いやすさの面で課題となります。転帰を最適化し、医療従事者の採用を促進するためには、これらの要素を適切にバランスさせることが重要です。

主な市場動向

1.個別化創傷ケアソリューション:

バイオポリマーをベースとしたドレッシング材は、個々の創傷の特徴に合わせた治療が可能な汎用性を備えています。この動向により、患者の満足度、治療計画の遵守、治癒成績が向上します。

2.スマートテクノロジーの統合:

センサーと電子部品を統合したスマートドレッシング材は、創傷ケア管理における革新的な動向です。これらのドレッシング材はリアルタイムのモニタリング、データ収集、患者関与の強化を提供し、治療成績の向上とヘルスケアコストの削減に貢献します。

セグメント別インサイト

タイプ別インサイト

バイオポリマーベースの創傷被覆材の世界市場では、キチン由来のキトサンが使用されるバイオポリマーの主流です。キトサンベースのドレッシング材は生体適合性と抗菌性を備えており、創傷ケアの要件に合致しています。

適応の洞察:

バイオポリマーベースの創傷被覆材は、糖尿病性潰瘍や静脈性下腿潰瘍などの潰瘍治療において優位性を発揮します。湿度調整特性と組織適合性により、潰瘍ケアに効果的です。

地域別の洞察

北米がバイオポリマーベース創傷被覆材の世界市場をリードしているのは、医療インフラの整備、先端技術、研究開発、規制の枠組みが整備されているためです。同地域は患者の転帰とケアの質を重視しており、バイオポリマーベースのドレッシング材の性能と一致しています。

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 臨床試験分析

第6章 バイオポリマーベース創傷被覆材の世界市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • タイプ別(キチン、キトサン、アルギン酸ナトリウム、アルギン酸カルシウム、その他)
    • 用途別(熱傷、潰瘍、切り傷、裂傷、その他)
    • エンドユーザー別(病院、外来手術センター、その他)
    • 地域別
    • 企業別(2022)
  • 製品マップ
    • タイプ別
    • 用途別
    • エンドユーザー別
    • 地域別

第7章 北米バイオポリマー創傷被覆材市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
  • 北米国別分析
    • 米国
    • カナダ
    • メキシコ

第8章 欧州:バイオポリマー創傷被覆材の市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
  • 欧州国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第9章 アジア太平洋地域のバイオポリマー創傷被覆材市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
  • アジア太平洋地域国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第10章 南米バイオポリマー創傷被覆材市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
  • 南米:国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東・アフリカのバイオポリマーベース創傷被覆材市場展望

  • 市場規模および予測
    • 金額別
  • 市場シェアと予測
    • タイプ別
    • 用途別
    • エンドユーザー別
    • 国別
  • MEA:国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第12章 市場力学

  • 促進要因
    • 慢性創傷の増加。
    • 先端技術への需要の高まり。
  • 課題
    • 高い治療費
    • 認識不足

第13章 市場動向と発展

  • 最近の展開
  • 合併と買収
  • 製品上市

第14章 バイオポリマーベースの創傷被覆材の世界市場SWOT分析

第15章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第16章 競合情勢

  • Business Overview
  • Product Offerings
  • Recent Developments
  • Financials(As Reported)
  • Key Personnel
  • SWOT Analysis
      • HemCon Medical Technologies, Inc
      • 3M Company
      • Integra LifeSciences Corporation
      • ConvaTec Group PLC
      • Smith & Nephew plc
      • Advancis Medical
      • Coloplast A/S
      • Lohmann & Rauscher GmbH & Co KG
      • Sorbsan
      • KiBou Pharma
      • Johnson & Johnson
      • Marine Polymer Technologies, Inc.
      • Advancis Medical

第17章 戦略的提言

目次
Product Code: 15882

The Global Biopolymer-Based Wound Dressing Market, valued at USD 340.78 Million in 2022, is poised for substantial growth in the forecast period, with a projected CAGR of 6.41% through 2028 and expected to reach USD 491.37 Million in 2028. This market represents a thriving segment within the medical industry, focusing on the development and utilization of wound dressings derived from biopolymers-naturally sourced or synthetically produced polymers. These wound dressings have garnered significant interest due to their biocompatibility, healing-promoting capabilities, and environmentally friendly nature.

In response to the growing demand for advanced wound care solutions, the market offers innovative products designed to address a variety of wound types, such as chronic wounds, surgical incisions, burns, and trauma-related injuries. This growth is fueled by factors including the rising prevalence of chronic diseases, an aging global population, and the need for more effective wound management. Biopolymer-based wound dressings offer unique advantages such as maintaining an optimal healing environment, minimizing infection risks, and enhancing patient comfort.

The market is marked by ongoing research and development efforts to enhance product properties, regulatory considerations to ensure safety and efficacy, and strategic collaborations to strengthen market presence. As healthcare systems emphasize efficient wound care and patient outcomes, the Global Biopolymer-Based Wound Dressing Market continues to play a crucial role in advancing medical treatment paradigms and addressing evolving wound care needs.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 340.78 Million
Market Size 2028USD 491.37 Million
CAGR 2023-20286.41%
Fastest Growing SegmentChitosan
Largest MarketNorth America

Key Market Drivers

1. Rising Prevalence of Chronic Wounds:

The increasing prevalence of chronic wounds, such as diabetic ulcers and pressure ulcers, is a significant driver of the Global Biopolymer-Based Wound Dressing Market. Biopolymer-based dressings offer tailored solutions to effectively manage and accelerate the healing of these wounds, which are characterized by prolonged healing times and increased infection risks. The prevalence of chronic wounds has risen due to factors like an aging population and the growing incidence of chronic diseases, contributing to the demand for these innovative dressings.

2. Eco-Friendly and Biocompatible Materials:

Growing environmental sustainability awareness and the need for biocompatible materials are driving the expansion of the market. Biopolymer-based dressings, sourced from renewable materials or bioengineered polymers, align with sustainability goals while offering enhanced biocompatibility.

3. Increasing Number of Surgical Procedures:

The rise in surgical procedures, resulting in post-operative wounds, is driving demand for biopolymer-based wound dressings. These dressings address the unique healing needs of surgical wounds, offering biocompatibility and optimal healing environments to accelerate wound closure and reduce complications.

Key Market Challenges

1. Limited Clinical Evidence:

The lack of robust clinical data supporting the efficacy of biopolymer-based wound dressings is a challenge to their adoption. Strong clinical evidence is crucial for establishing safety, effectiveness, and value, and overcoming this challenge requires comprehensive research and collaboration.

2. High Cost:

The production processes and unique material characteristics of biopolymer-based dressings can lead to higher costs compared to traditional dressings. This cost challenge impacts pricing, affordability, and reimbursement decisions.

3. Varied Wound Types:

Addressing a wide spectrum of wound types poses a challenge in terms of customization, standardization, and ease of use. Striking the right balance between these factors is crucial for optimizing outcomes and facilitating healthcare provider adoption.

Key Market Trends

1. Personalized Wound Care Solutions:

The trend of personalized wound care solutions is gaining momentum, with biopolymer-based dressings offering versatility for tailoring treatments to individual wound characteristics. This trend enhances patient satisfaction, adherence to treatment plans, and healing outcomes.

2. Integration of Smart Technology:

Smart dressings, integrating sensors and electronic components, represent a transformative trend in wound care management. These dressings offer real-time monitoring, data collection, and enhanced patient engagement, contributing to better outcomes and reduced healthcare costs.

Segmental Insights

Type Insights:

Chitosan, derived from chitin, is the dominant type of biopolymer used in the Global Biopolymer-Based Wound Dressing Market. Chitosan-based dressings offer biocompatibility and antimicrobial properties, aligning well with wound care requirements.

Indication Insights:

Biopolymer-based wound dressings find dominance in treating ulcers, including diabetic ulcers and venous leg ulcers. Their moisture-regulating properties and tissue compatibility make them effective for ulcer care.

Regional Insights:

North America leads the Global Biopolymer-Based Wound Dressing Market due to its developed healthcare infrastructure, advanced technologies, research focus, and regulatory framework. The region's emphasis on patient outcomes and quality of care aligns with the capabilities of biopolymer-based dressings.

In summary, the Global Biopolymer-Based Wound Dressing Market is poised for robust growth, driven by various factors such as the rising prevalence of chronic wounds, eco-friendly materials, and the integration of smart technology. However, challenges like limited clinical evidence, cost concerns, and addressing varied wound types need to be addressed to fully capitalize on the market's potential. As the market embraces trends like personalized care and smart technology integration, biopolymer-based wound dressings will play a pivotal role in shaping the future of wound care management.

Key Market Players

  • HemCon Medical Technologies, Inc.,
  • 3M Company
  • Integra LifeSciences Corporation
  • ConvaTec Group PLC
  • Smith & Nephew plc
  • Advancis Medical
  • Coloplast A/S
  • Lohmann & Rauscher GmbH & Co KG
  • Sorbsan
  • KiBou Pharma
  • Johnson & Johnson
  • Marine Polymer Technologies, Inc.
  • Advancis Medical

Report Scope:

In this report, the Global Biopolymer Based Wound Dressing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below.

Biopolymer Based Wound Dressing Market, By Type:

  • Chitin
  • Chitosan
  • Sodium Alginate
  • Calcium Alginate
  • Others

Biopolymer Based Wound Dressing Market, By Applications:

  • Burns
  • Ulcers
  • Cuts and Lacerations
  • Others

Biopolymer Based Wound Dressing Market, By End User:

  • Hospitals
  • Ambulatory Surgery Center
  • Others

Biopolymer Based Wound Dressing Market, By region:

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Biopolymer Based Wound Dressing Market.

Available Customizations:

  • Global Biopolymer Based Wound Dressing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

  • 5.1. Ongoing Clinical Trials
  • 5.2. Completed Clinical Trials
  • 5.3. Terminated Clinical Trials
  • 5.4. Breakdown of Pipeline, By Development Phase
  • 5.5. Breakdown of Pipeline, By Status
  • 5.6. Breakdown of Pipeline, By Study Type
  • 5.7. Breakdown of Pipeline, By Region
  • 5.8. Clinical Trials Heat Map

6. Global Biopolymer Based Wound Dressing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Chitin, Chitosan, Sodium Alginate, Calcium Alginate, Others)
    • 6.2.2. By Application (Burns, Ulcers, Cuts and Lacerations, Others)
    • 6.2.3. By End User (Hospitals, Ambulatory Surgery Centers, Others)
    • 6.2.4. By Region
    • 6.2.5. By Company (2022)
  • 6.3. Product Map
    • 5.3.1 By Type
    • 5.3.2 By Application
    • 5.3.3 By End User
    • 5.3.4 By Region

7. North America Biopolymer Based Wound Dressing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Chitin, Chitosan, Sodium Alginate, Calcium Alginate, Others)
    • 7.2.2. By Application (Burns, Ulcers, Cuts and Lacerations, Others)
    • 7.2.3. By End User (Hospitals, Ambulatory Surgery Centers, Others)
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Biopolymer Based Wound Dressing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. Canada Biopolymer Based Wound Dressing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. Mexico Biopolymer Based Wound Dressing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User

8. Europe Biopolymer Based Wound Dressing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (Chitin, Chitosan, Sodium Alginate, Calcium Alginate, Others)
    • 8.2.2. By Application (Burns, Ulcers, Cuts and Lacerations, Others)
    • 8.2.3. By End User (Hospitals, Ambulatory Surgery Centers, Others)
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Biopolymer Based Wound Dressing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. Germany Biopolymer Based Wound Dressing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. United Kingdom Biopolymer Based Wound Dressing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecasty
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. Italy Biopolymer Based Wound Dressing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Spain Biopolymer Based Wound Dressing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Asia-Pacific Biopolymer Based Wound Dressing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Chitin, Chitosan, Sodium Alginate, Calcium Alginate, Others)
    • 9.2.2. By Application (Burns, Ulcers, Cuts and Lacerations, Others)
    • 9.2.3. By End User (Hospitals, Ambulatory Surgery Centers, Others)
    • 9.2.4. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Biopolymer Based Wound Dressing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. India Biopolymer Based Wound Dressing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Japan Biopolymer Based Wound Dressing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User
    • 9.3.4. South Korea Biopolymer Based Wound Dressing Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Application
        • 9.3.4.2.3. By End User
    • 9.3.5. Australia Biopolymer Based Wound Dressing Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Application
        • 9.3.5.2.3. By End User

10. South America Biopolymer Based Wound Dressing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (Chitin, Chitosan, Sodium Alginate, Calcium Alginate, Others)
    • 10.2.2. By Application (Burns, Ulcers, Cuts and Lacerations, Others)
    • 10.2.3. By End User (Hospitals, Ambulatory Surgery Centers, Others)
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Biopolymer Based Wound Dressing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina Biopolymer Based Wound Dressing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia Biopolymer Based Wound Dressing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Middle East and Africa Biopolymer Based Wound Dressing Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type (Chitin, Chitosan, Sodium Alginate, Calcium Alginate, Others)
    • 11.2.2. By Application (Burns, Ulcers, Cuts and Lacerations, Others)
    • 11.2.3. By End User (Hospitals, Ambulatory Surgery Centers, Others)
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Biopolymer Based Wound Dressing Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Application
        • 11.3.1.2.3. By End User
    • 11.3.2. Saudi Arabia Biopolymer Based Wound Dressing Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Application
        • 11.3.2.2.3. By End User
    • 11.3.3. UAE Biopolymer Based Wound Dressing Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Application
        • 11.3.3.2.3. By End User

12. Market Dynamics

  • 12.1. Drivers
    • 12.1.1 Rise in Incidence of Chronic wound.
    • 12.1.2 Growing Demand for Advance Technologies.
  • 12.2. Challenges
    • 12.2.1 High Treatment Cost
    • 12.2.2 Lack of Awareness

13. Market Trends & Developments

  • 13.1. Recent Development
  • 13.2. Mergers & Acquisitions
  • 13.3. Product Launches

14. Global Biopolymer Based Wound Dressing Market: SWOT Analysis

15. Porter's Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products

16. Competitive Landscape

  • 16.1. Business Overview
  • 16.2. Product Offerings
  • 16.3. Recent Developments
  • 16.4. Financials (As Reported)
  • 16.5. Key Personnel
  • 16.6. SWOT Analysis
      • 16.6.1.1. HemCon Medical Technologies, Inc
      • 16.6.1.2. 3M Company
      • 16.6.1.3. Integra LifeSciences Corporation
      • 16.6.1.4. ConvaTec Group PLC
      • 16.6.1.5. Smith & Nephew plc
      • 16.6.1.6. Advancis Medical
      • 16.6.1.7. Coloplast A/S
      • 16.6.1.8. Lohmann & Rauscher GmbH & Co KG
      • 16.6.1.9. Sorbsan
      • 16.6.1.10. KiBou Pharma
      • 16.6.1.11. Johnson & Johnson
      • 16.6.1.12. Marine Polymer Technologies, Inc.
      • 16.6.1.13. Advancis Medical

17. Strategic Recommendations